Sachdev Amit
Transaction: 07/21/2026
BUY
Change
+8,251
Price
Not reported
Filing
07/23/2026
Type
BUY
Vertex Pharmaceuticals Incorporated
VRTX • Biotechnology
$546.12
▼ -11.84 (-2.12%)
Current price
EarningsLatest report: Jun 30, 2026
FAVORABLE PROFILEAttractiveConfidence: 70%
Quantitative profile — not an investment recommendation.
Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Strong business quality with supportive growth and cash-flow evidence. Valuation still matters, but the historical ratio profile is favorable.
Market Cap
$123.05B
Growth
18.7%
Cash Flow
4/5
Trend
Mostly stable
Evidence
Stable or improving margins · 32.7%Positive revenue growth · 12.6%Positive free cash flow · 12.49Consistent free cash flow · 4/5Manageable debt level · 0.21
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 12:09 PM UTC
Company Snapshot
Key valuation, quality, financial strength, momentum and analyst data.
Price$546.12
Change-2.12%
Market Cap$123.05B
52W Range362.50 - 533.67
Beta0.29
Gross Margin85.03%
Oper. Margin39.43%
Profit Margin32.74%
Debt/Eq0.21
Current Ratio2.90
Quick Ratio2.46
Revenue 5Y18.70%
Price$546.12
Change-2.12%
Market Cap$123.05B
52W Range362.50 - 533.67
Beta0.29
Gross Margin85.03%
Oper. Margin39.43%
Profit Margin32.74%
Debt/Eq0.21
Current Ratio2.90
Quick Ratio2.46
Revenue 5Y18.70%
Target$552.93
Target Upside1.25%
Target Median$576.00
Target Range350.00 - 617.00
Volume1.13M
Avg Volume1.49M
EPS Surprise0.23
Investment DNA
How strong this company looks for long-term investors
80
out of 100
Business Quality
Margins, moat, returns
90/100
Financial Strength
Debt, cash, stability
95/100
Growth Potential
Revenue and expansion
87/100
Price Attractiveness
Cheap or expensive today
38/100
Why this score▼
Stable or improving margins · 32.7%Positive revenue growth · 12.6%Positive free cash flow · 12.49Consistent free cash flow · 4/5Manageable debt level · 0.21Healthy liquidity · 2.9
Analyst view
Analyst sentiment and price target
Analyst sentiment
No vote count available
Bullish
0
Hold
0
Bearish
0
Price Target
2026-08-06
Low
$350.00
Mean
$552.93
Median
$576.00
High
$617.00
Insider Transactions
Recent executive and insider activity
Tatsis Ourania
Transaction: 07/21/2026
BUY
Change
+8,251
Price
Not reported
Filing
07/23/2026
Type
BUY
Garber Alan M
Transaction: 07/15/2026
BUY
Change
—
Price
Not reported
Filing
07/17/2026
Type
BUY
| Insider | Type | Change | Price | Transaction | Filing |
|---|---|---|---|---|---|
| Sachdev Amit | BUY | +8,251 | Not reported | 07/21/2026 | 07/23/2026 |
| Tatsis Ourania | BUY | +8,251 | Not reported | 07/21/2026 | 07/23/2026 |
| Garber Alan M | BUY | — | Not reported | 07/15/2026 | 07/17/2026 |
| SACHS BRUCE I | BUY | — | Not reported | 07/15/2026 | 07/17/2026 |
| McKechnie Duncan | SELL | -1,541 | $519.00 | 07/02/2026 | 07/07/2026 |
| Tatsis Ourania | SELL | -1,500 | $524.99 | 07/02/2026 | 07/07/2026 |
| Liu Joy | SELL | -828 | $502.71 | 07/01/2026 | 07/06/2026 |
| Bozic Carmen | SELL | -596 | $482.50 | 06/26/2026 | 06/30/2026 |
| Bozic Carmen | SELL | -1,020 | $462.17 | 06/18/2026 | 06/23/2026 |
| Bozic Carmen | SELL | -4,062 | $450.00 | 06/15/2026 | 06/17/2026 |
| Bozic Carmen | SELL | -1,745 | $450.00 | 06/05/2026 | 06/09/2026 |
| Bozic Carmen | SELL | -1,974 | $450.00 | 05/29/2026 | 06/02/2026 |
| Bozic Carmen | SELL | -1,354 | $453.45 | 05/15/2026 | 05/19/2026 |
| Bunnage Mark E. | SELL | -33 | $453.45 | 05/15/2026 | 05/19/2026 |
| Bozic Carmen | SELL | -6,988 | $450.00 | 05/12/2026 | 05/14/2026 |
| Bhatia Sangeeta N. | SELL | -318 | $423.73 | 05/04/2026 | 05/05/2026 |
| Bhatia Sangeeta N. | BUY | +943 | Not reported | 05/01/2026 | 05/05/2026 |
| CARNEY LLOYD | BUY | +2,866 | $424.45 | 05/01/2026 | 05/05/2026 |
| Garber Alan M | BUY | +1,433 | $424.45 | 05/01/2026 | 05/05/2026 |
| Garber Alan M | BUY | +472 | Not reported | 05/01/2026 | 05/05/2026 |